Fatty liver drug trial in HIV patients ends early
NCT ID NCT05211284
First seen Nov 01, 2025 · Last updated May 08, 2026 · Updated 25 times
Summary
This study tested a drug called saroglitazar magnesium for nonalcoholic fatty liver disease (NAFLD) in people living with HIV. The goal was to see if it could reduce liver fat compared to a placebo. The trial was stopped early and only enrolled 4 participants, so no conclusions can be drawn.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NONALCOHOLIC FATTY LIVER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Zydus US001
Durham, North Carolina, 27710, United States
-
Zydus US002
Indianapolis, Indiana, 46202, United States
-
Zydus US003
Baltimore, Maryland, 21287, United States
-
Zydus US004
Birmingham, Alabama, 35294-2050, United States
-
Zydus US005
La Jolla, California, 92037, United States
-
Zydus US006
San Francisco, California, 94143, United States
-
Zydus US007
Houston, Texas, 77030, United States
-
Zydus US008
Richmond, Virginia, 23298, United States
Conditions
Explore the condition pages connected to this study.